Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF (PBE) Implied Volatility Current
PBE's 30 day implied volatility is 31.35%, with an IV Rank of 97.22%. This is a high IV Rank versus the past year, meaning Invesco Biotechnology & Genome ETF options are relatively expensive and currently favor sellers. PBE's 30 day historical volatility sits at 27.68%, which means implied volatility is running 3.67 points above historical volatility, as of Nov 20, 2026.
Read more
Tracking PBE implied volatility helps you spot when Invesco Biotechnology & Genome ETF options are historically cheap or expensive, and where the best trades are hiding. When PBE IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor PBE implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking PBE IV rank helps you see whether PBE's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →